Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Picard MedicalPMI -3.11%4 Debt-to-Equity is -2.26 as of Mar. 2026. GuruFocus rates PMI with a GF Score™ of 4/100. The stock has 4 warning signs investors should review. Among 704 Medical Devices & Instruments companies, Picard Medical ranks worse than 142045.31% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Picard Medical's Debt-to-Equity or its related term are showing as below:
PMI'
s Debt-to-Equity Range Over the Past 10 Years
Min: -2.65 Med: -0.88 Max: 1.84
Current: -2.26
During the past 4 years, the highest Debt-to-Equity Ratio of Picard Medical was 1.84. The lowest was -2.65. And the median was -0.88.
PMI's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.23
vs PMI: -2.26
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Picard Medical Debt-to-Equity Related Terms
Picard Medical Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Picard Medical's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PMI vs SINT, HSCS, CODX: Debt-to-Equity Comparison
For the Medical Devices subindustry, Picard Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Picard Medical Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Picard Medical's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Picard Medical's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Picard Medical (PMI) has a Debt-to-Equity of -2.26 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Picard Medical and its competitors. According to the industry distribution chart, Picard Medical ranks #999999 out of 704 companies in the Medical Devices & Instruments industry.
Is Picard Medical's Debt-to-Equity too high?
Picard Medical's current Debt-to-Equity is -2.26. Based on the distribution chart, Picard Medical ranks #999999 out of 704 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Picard Medical has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Picard Medical's Debt-to-Equity compare to SINT and HSCS?
According to the Medical Devices & Instruments industry distribution chart, Picard Medical ranks #999999 out of 704 companies for Debt-to-Equity. This places Picard Medical in the lower half of its industry. The industry median Debt-to-Equity is 0.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Picard Medical and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Picard Medical's current Debt-to-Equity is -2.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Picard Medical stock overvalued right now?
Picard Medical (PMI) has a current Debt-to-Equity of -2.26. The current Debt-to-Equity is -2.26. Picard Medical's overall GF Score™ is 4/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Picard Medical (PMI), the current Debt-to-Equity is -2.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.
4GF Score
Get the complete analysis for PMI
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMI has been successfully added to your 
